Dr. Berry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 888-631-2452Fax+1 323-442-6338
Summary
- Dr. Jesse Berry is an ophthalmologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including VA Greater Los Angeles Healthcare System, LAC+USC Medical Center, and Keck Hospital of USC. She received her medical degree from Harvard Medical School and has been in practice 9 years. She also speaks multiple languages, including Spanish. She specializes in ocular oncology and is experienced in treatment of retinoblastoma, uveal melanoma, ocular surface tumors, and other ophthalmic oncology surgery.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2009 - 2012
- Harvard Medical SchoolClass of 2008
- Harvard CollegeA.B., Biochemical Sciences. Minor in Spanish, Cum Laude, 2000 - 2004
Certifications & Licensure
- CA State Medical License 2009 - 2025
- AZ State Medical License 2016 - 2020
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Society of Heed Fellows 2013
- Excellence in Resident Teaching Award University of Southern California, 2013
- Heed Ophthalmic Foundation Fellow 2013
- Join now to see all
Publications & Presentations
PubMed
- Discrimination Within the US Ophthalmology Workforce.Shreya Sirivolu, Sarah Pike, Mark W Reid, Jesse L Berry, Melinda Y Chang
JAMA Ophthalmology. 2024-12-05 - Single-cell somatic copy number alteration profiling of vitreous humor seeds in retinoblastoma.Shreya Sirivolu, Michael J Schmidt, Rishvanth K Prabakar, Peter Kuhn, James Hicks
Ophthalmic Genetics. 2024-12-01 - Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma.Mattan Arazi, Alona Baum, Sandro Casavilca-Zambrano, Sandra Alarcon-Leon, Rosdali Diaz-Coronado
American Journal of Ophthalmology. 2024-12-01
Journal Articles
- Outcomes of Medium-sized Choroidal Melanomas Treated with USC Eye Physics(R) Plaques: 20-year ReviewBerry JL, Dandapani SV, Stevanovic M, Astrahan M, Lee TC, Murphree AL, Kim JW, 9/5/2013
- Long term Outcomes of Group D Eyes in Bilateral Retinoblastoma Patients Treated with Chemoreduction and Low-dose IMRT SalvageBerry JL, Jubran R, Kim JW, Wong KE, Almarzouki H, Lee TC, Murphree AL, Pediatr Blood Cancer, 4/1/2013
- Los Angeles County-University of Southern California Residents Review: "Cataract Surgery with Trabecular Micro-bypass Stent Implantation in Patients with Mild-to-moder...Swamy R, Berry J, Huang A, Vazquez L, Eye World, 8/1/2012
- Join now to see all
Press Mentions
- How a New Test Is Transforming Care for RetinoblastomaDecember 12th, 2024
- Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid TumorsMarch 2nd, 2023
- Liquid Biopsy Test for Children’s Solid Tumors DevelopedMarch 2nd, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: